適用於3歲以上兒童及成人之主動免疫接種，藉以預防此疫苗所涵蓋之兩種A型流感病毒及兩種B型流感病毒所引起的流行性感冒。

Biologic and Immunologic Agents/ Immunizations/ Vaccines-Virus (Inactivated)

Hypersensitivity to a previous influenza vaccination or to any component of the formulation.

>10%: anorexia (infants, children, and adolescents: 9% to 32%; adults and older adults: 4% to 8%), diarrhea (4% to 24%), nausea (≤12%), vomiting, erythema at injection site (1% to 37%), induration at injection site (≤17%), pain at injection site (17% to 67%), swelling at injection site (≤25%), tenderness at injection site (21% to 69%), drowsiness (infants and children: 8% to 38%), fatigue (≤22%), headache (1% to 27%), irritability (infants and children: 2% to 54%), malaise (≤38%), uncontrolled crying (infants and children: 33% to 41%), arthralgia (4% to 15%), myalgia (3% to 40%), cough (infants, children, and adolescents: 1% to 15%), rhinorrhea (infants and children: 1% to 11%), wheezing, fever (infants, children, and adolescents: 1% to 16%; adults and older adults: ≤4%).

IM. Adult: 0.5 mL/dose as a single dose per season.

IM, ≥9 years old: 0.5 mL/dose as a single dose per season.
IM, 3-8 years old:
a.0.5 mL/dose
b. Who have not previously been vaccine against influenza should receive a second dose of 0.5 mL after an interval of at least 4 weeks.